moxifloxacin has been researched along with Pott Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, SM; Kaur, H; Mittal, GK; Reddy, VASK | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
2 other study(ies) available for moxifloxacin and Pott Disease
| Article | Year |
|---|---|
Moxifloxacin induced encephalopathy in disseminated tuberculosis: A case report.
Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Deprescriptions; Discitis; Electroencephalography; Encephalitis; Humans; Male; Moxifloxacin; Neurotoxicity Syndromes; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tuberculosis, Spinal | 2020 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |